Novel Immortal Cell Lines Support Cellular Heterogeneity in the Human Annulus Fibrosus

PLoS One. 2016 Jan 21;11(1):e0144497. doi: 10.1371/journal.pone.0144497. eCollection 2016.

Abstract

Introduction: Loss of annulus fibrosus (AF) integrity predisposes to disc herniation and is associated with IVD degeneration. Successful implementation of biomedical intervention therapy requires in-depth knowledge of IVD cell biology. We recently generated unique clonal human nucleus pulposus (NP) cell lines. Recurring functional cellular phenotypes from independent donors provided pivotal evidence for cell heterogeneity in the mature human NP. In this study we aimed to generate and characterize immortal cell lines for the human AF from matched donors.

Methods: Non-degenerate healthy disc material was obtained as surplus surgical material. AF cells were immortalized by simian virus Large T antigen (SV40LTAg) and human telomerase (hTERT) expression. Early passage cells and immortalized cell clones were characterized based on marker gene expression under standardized culturing and in the presence of Transforming Growth factor β (TGFβ).

Results: The AF-specific expression signature included COL1A1, COL5A1, COL12A1, SFRP2 and was largely maintained in immortal AF cell lines. Remarkably, TGFβ induced rapid 3D sheet formation in a subgroup of AF clones. This phenotype was associated with inherent differences in Procollagen type I processing and maturation, and correlated with differential mRNA expression of Prolyl 4-hydroxylase alpha polypeptide 1 and 3 (P4HA1,3) and Lysyl oxidase (LOX) between clones and differential P4HA3 protein expression between AF cells in histological sections.

Conclusion: We report for the first time the generation of representative human AF cell lines. Gene expression profile analysis and functional comparison of AF clones revealed variation between immortalized cells and suggests phenotypic heterogeneity in the human AF. Future characterization of AF cellular (sub-)populations aims to combine identification of additional specific AF marker genes and their biological relevance. Ultimately this knowledge will contribute to clinical application of cell-based technology in IVD repair.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ADAM Proteins / metabolism
  • ADAMTS Proteins
  • Adolescent
  • Biomarkers / metabolism
  • Cartilage Oligomeric Matrix Protein / metabolism
  • Cell Line, Transformed / drug effects
  • Cell Line, Transformed / metabolism
  • Collagen Type I / metabolism
  • Collagen Type I, alpha 1 Chain
  • Collagen Type II / genetics
  • Collagen Type II / metabolism
  • Collagen Type V / genetics
  • Collagen Type V / metabolism
  • Female
  • Humans
  • Intervertebral Disc / cytology*
  • Intervertebral Disc / physiology*
  • Male
  • Membrane Proteins / genetics
  • Membrane Proteins / metabolism
  • Procollagen-Proline Dioxygenase / genetics
  • Procollagen-Proline Dioxygenase / metabolism
  • Transforming Growth Factor beta / pharmacology
  • Transforming Growth Factor beta3 / pharmacology

Substances

  • Biomarkers
  • COL2A1 protein, human
  • COL5A1 protein, human
  • COMP protein, human
  • Cartilage Oligomeric Matrix Protein
  • Collagen Type I
  • Collagen Type I, alpha 1 Chain
  • Collagen Type II
  • Collagen Type V
  • Membrane Proteins
  • SFRP2 protein, human
  • Transforming Growth Factor beta
  • Transforming Growth Factor beta3
  • P4HA3 protein, human
  • Procollagen-Proline Dioxygenase
  • ADAM Proteins
  • ADAMTS Proteins
  • ADAMTS17 protein, human

Grants and funding

This study was supported by Project P2.01 IDiDAS (LWvR, TJMW); LLP14 Grant Dutch Arthritis Foundation (JWV, LWvR); Programme for Advanced Medical Education, Fundação Calouste Gulbenkian, Fundação Champalimaud, Ministério da Saúde, Fundação para a Ciência e Tecnologia and Apifarma, Portugal. None of the funding sources had any role in study design, data collection, analysis and interpretation, writing of the manuscript or the decision to submit the manuscript for publication.